BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Protherics

We are a biopharmaceutical business, with approximately 125 employees and operations in the United Kingdom, United States and Australia. We are focused on immunotherapeutic research and development, and were formed in September 1999 through the merger of Proteus International Plc and Therapeutic Antibodies Inc.

Our products are based on two proprietary technology platforms:



Highly purified polyclonal antibodies for acute medical emergency applications. These products are in late stage development or already on the market and include CroFab™, DigiFab™ and CytoTAb® .

Novel peptide-conjugate vaccines to treat chronic diseases. These products are in pre-clinical or clinical development and include GnRH(gonadotropin releasing hormone) and angiotensin vaccines.


Contact Details:
The Health Business and Technical Park
Runcorn
Cheshire
W47 4QF
United Kingdom
Tel:01928 518 000
Fax:01928 518 002
Email:barry.riley@protherics.com
WWW:

www.protherics.co.uk/




Recent Publications by Protherics:

Pharmacokinetics of glucarpidase in subjects with normal and impaired renal function.
Glucarpidase (formerly known as carboxypeptidase G2 or CPG2) is being...
20th May, 2008
Protherics PLC, The Heath Business & Technical Park, Runcorn, Cheshire, J Clin Pharmacol. 2008 Mar;48(3):279-84. Epub 2008 Jan 11.
DOI Direct Link
Optimal conditions for the papain digestion of polyclonal ovine IgG for the production of bio-therapeutic Fab fragments.
In the present paper, we describe a rapid method for the determination of...
8th March, 2008
Process Development Group, Protherics U.K. Ltd, Blaenwaun, Ffostrasol, Biotechnol Appl Biochem. 2005 Oct;42(Pt 2):163-8.
DOI Direct Link
Antibody production: polyclonal-derived biotherapeutics.
Antibody based therapies using monoclonal or polyclonal antibodies are...
22nd May, 2007
Process Development Group, Protherics UK Ltd, Blaenwaun, Ffostrasol, J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Mar 15;848(1):2-7.
DOI Direct Link
Optimised affinity purification of polyclonal antibodies from hyper immunised ovine serum using a synthetic Protein A adsorbent, MAbsorbent A2P.
This report describes the applicability of a synthetic chromatography...
19th May, 2005
Process Development Group, Protherics Ltd., Blaenwaun, Ffostrasol, J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jan 25;814(2):209-15.
DOI Direct Link
Evaluation of two carrier protein-angiotensin I conjugate vaccines to assess their future potential to control high blood pressure (hypertension) in man.
AIMS: We aim to modulate the renin-angiotensin system (RAS) by active...
3rd February, 2004
Protherics plc. (PMD), The Heath Business & Technical Park, Runcorn, UK. Br J Clin Pharmacol. 2003 Nov;56(5):505-12.

View more Protherics research publications.

BioNews Results for Protherics:

Protherics PLC - Holding(s) in Company
Genetic Engineering News:  Aug 29 2008 5:49PM Matching: protherics
Techmark movers: Oxford and Alizyme fall
City A.M.:  Aug 29 2008 4:08PM Matching: protherics
Protherics begin proof-of-concept study for Prolarix in HCC
Pharma Times:  Aug 28 2008 3:34PM Matching: protherics
Protherics initiates Phase IIa liver cancer study
Pharmaceutical Business Review:  Aug 28 2008 8:56PM Matching: protherics
Protherics Initiates Phase IIa Liver Cancer Study
Red Orbit:  Aug 28 2008 4:51PM Matching: protherics
Promote your company here: BioNewsCast - Press Release Distribution

View more Protherics news.

Protherics Patents:

US Patent No.Title
7378489 Angiotensin derivatives
6833131 Antivenom immunesera
6262069 1-amino-7-isoquinoline derivatives as serine protease inhibitors
6193969 Antibody fragments in therapy

Protherics (PTIL) Financial information Links from Barchart

PTIL Quote from from Barchart.com
PTIL Chart from from Barchart.com
PTIL Profile from from Barchart.com
PTIL Opinion from from Barchart.com

View more Protherics finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 330 times since April 2007, the link to the organisation's website has been followed 48 times

Recent Search Terms used to find this page: t | t | protherics com | @protherics.com | @protherics.com email | protherics technical park | protherics.com | Protherics.com | Cytotab | Protherics Medicines Development | .

Search for more companies in Runcorn

Search for more companies in Cheshire



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Protherics
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.